 Market - Industry Outlook and Forecast 2021-2026-1625459165.png)
Have a question?
Please get in touch with our team in case of any queries
U.S. IN-VITRO FERTILIZATION MARKET SIZE TO REACH USD 231.68 MILLION BY 2026, GROWING AT A CAGR OF 5.45% DURING THE PERIOD 2021-2026
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
U.S. IN-VITRO FERTILIZATION MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| MARET SIZE (REVENUE) | USD 231.68 MILLION (2026) |
| CAGR | 5.45% (2021-2026) |
| Base Year | 2020 |
| Historic Year | |
| Forecast Year | 2021-2026 |
| Market Segments | Products (Consumables, Media, and Equipment), End-Users (Fertility Clinics, Hospitals, and Others), and Donor Type (Fresh Non-Donor, Frozen Non-Donor, Fresh Donor, and Frozen Donor) |
| Geographic Analysis | United States |
| Countries Covered |
U.S. IN-VITRO FERTILIZATION INDUSTRY INSIGHTS
The U.S. in-vitro fertilization market size was valued at USD 168.5 million in 2020 and is expected to reach USD 231.68 million by 2026, growing at a CAGR of 5.45% during the forecast period. The consumables segment is likely to witness the highest absolute growth of 43.16% in the U.S. IVF market.
Over the past few years, the infertility treatment market has been growing at a healthy rate because of rising awareness regarding the availability of various infertility treatment options through the government. Vendors advocating IVF awareness and campaigns are increasing the acceptance of IVF procedures and a surge in fertility tourism, which boosts the growth of the U.S. IVF market. Technological advancements and innovations are being majorly focused on by the fertility clinics and fertility treatment centers to improve the treatment outcomes, surging the growth of the IVF market. Some modern in-vitro fertilization technologies are assisted hatching, Cult-Active, EmbryoGen, Embryo glue, and Intracytoplasmic sperm injection. Investors are purchasing and acquiring fertility clinics with a high success rate of fertility treatment. New investors are discovering the attractiveness of infertility treatment after seeing the success of recent investments and establishing fertility clinics with sophisticated infrastructure.
KEY HIGHLIGHTS
- The consumables segment is likely to witness the highest absolute growth of 43.16% in the U.S. in-vitro fertilization (IVF) market during the forecast period compared to media and equipment product segments.
- As the market is witnessing the increased demand for infertility treatments, this created huge competition among the vendors to offer a wide range of innovative media, consumables, and the devices necessary for infertility treatment.
- Japan, India, and the U.S. have a greater number of in-vitro fertilization clinics compared to other countries.
U.S. IN-VITRO FERTILIZATION INDUSTRY GROWTH FACTORS
- The in-vitro fertilization market has the huge potential to grow as there is an increased prevalence rate of infertility in men and women among the US population.
- By the year 2030, obesity will be a severe and alarming disorder among the US population, which will significantly impact the reproductive health of both males and females. This will boost the growth of the U.S. in-vitro fertilization market share.
- The growing popularity of single women opting for motherhood through organizations such as Single Mothers by Choice and Choice Mom fuels the demand for ARTs.
SEGMENTATION ANALYSIS
- End-users majorly use various consumables and related accessories to maintain sterility and perform various stages of in-vitro fertilization procedures. The US in-vitro fertilization devices market by consumables is expected to reach USD 101.96 million by 2026.
- IVF procedures are witnessing an improved overall success rate due to the higher availability of a broad range of culture media. The commercial media manufactured by the key players in the U.S. in-vitro fertilization market are focused on developing media containing various components, including nutrients, vitamins, and growth factors.
- Various companies are strategizing to grow by increasing their focus on mergers & acquisitions and collaborating with other companies to implement artificial intelligence in embryo assessment. Such innovative technologies help in boosting the market for infertility treatments.
- The fertility clinics captured the maximum market share due to the high success rates of fertility treatments and increased awareness of IVF procedures. The Advanced Fertility Center of Chicago had the highest success rates in patients aged between 38 – 40 and the live birth rate per transfer 74.2%.
- The implementation of advanced technologies like fertility clinics in the hospital setting can significantly boost the hospitals' revenues. In-vitro fertilization devices market in the US by hospitals to witness an absolute growth of 24.99% by 2026.
VENDOR LANDSCAPE
The US in-vitro fertilization market is characterized by the presence of global, regional, and local vendors. In recent years, the global infertility treatment market has witnessed many strategic initiatives by key vendors, which is expected to intensify market competitiveness in the upcoming years. Infertility treatment is a niche industry with high margins for manufacturers, especially for vendors offering equipment, media, and related consumables, that are widely used during ART procedures. Players are expected to have active participation in the U.S. in-vitro fertilization market to maximize profit.
The U.S. in-vitro fertilization market research report will include in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
Segmentation by Products
- Consumables
- Media
- Equipment
Segmentation by End-Users
- Fertility Clinics
- Hospitals
- Others
Segmentation by Donor Type
- Fresh Non-Donor
- Frozen Non-Donor
- Fresh Donor
- Frozen Donor
Frequently Asked Questions
How big is the U.S. IVF market?
What is the growth rate of the US in vitro fertilization (IVF) market?
Which segment accounted for the largest in-vitro fertilization market share?
Who are the key players in the US in-vitro fertilization market?
What are some of the technological advancements and innovations in the IVF market?
The U.S. in-vitro fertilization market by revenue is expected to grow at a CAGR of 5.45% during the period 2021–2026.
The following factors are likely to contribute to the growth of the U.S. in-vitro fertilization market during the forecast period:
- Technological Advancements & Innovations in IVF
- Increasing Private Equity/Venture Capital Funding in IVF Clinics
- Rising Number of Obesity Cases
- Increasing Number of Fertility Clinics Offering Fertility Services
Base Year: 2020
Forecast Year: 2021-2026
The study considers the present scenario of the U.S. In-vitro fertilization market and its market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Prominent Vendors
- The Cooper Companies
- Business Overview
- Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
- Cook Medical
- Vitrolife
- FUJIFILM Irvine Scientific
- Merck Group
- Hamilton Thorne
Other Prominent Vendors
- CARL ZEISS
- Business Overview
- Product Offerings
- Kitazato USA
- Rocket Medical
- Thermo Fisher Scientific
- Thomas Medical
- Nidacon
- Esco Lifesciences
- GYNEMED
Segmentation by Products
- Consumables
- Media
- Equipment
Segmentation by End-Users
- Fertility Clinics
- Hospitals
- Others
Segmentation by Donor Type
- Fresh Non-Donor
- Frozen Non-Donor
- Fresh Donor
- Frozen Donor
Exhibit 1 Segmentation of IVF Devices Market in US
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Common Causes of Infertility (% share)
Exhibit 4 Steps Involved in IVF Procedure
Exhibit 5 Impact of Technological Advances & Innovations in IVF
Exhibit 6 Impact of Single Parents & Same-Sex Couples Taking Infertility Treatments
Exhibit 7 Same-Sex Married Couples in US 2010-2019
Exhibit 8 Impact of Financial Assistance Programs & Employer Benefits for Infertility Treatment
Exhibit 9 Impact of Private Equity/Venture Capital Funding in IVF Clinics
Exhibit 10 Birth Rates Comparison by Mother’s Age Group in US 1980-2017
Exhibit 11 Impact of Increasing Prevalence of Infertility
Exhibit 12 Projected Number of Women in US with Infertility 1988-2025 (million)
Exhibit 13 Impact of Rising Obesity Cases Infertility
Exhibit 14 Growing Prevalence of Obesity 2012-2030 (% share)
Exhibit 15 Impact of Increasing Acceptance of ART Procedures
Exhibit 16 Projected Number of Women in US with Infertility 1988-2025 (million)
Exhibit 17 Number of Infants Born and ART Procedures Performed in US in Thousands (2002−2011)
Exhibit 18 Impact of Rise in Number of Fertility Clinics
Exhibit 19 ART Cycles Performed by Region 2018 (% share)
Exhibit 20 Highest Number of Fertility Clinics in the US in 2017
Exhibit 21 ART-Conceived Infants in US 2017 (% share)
Exhibit 22 Impact of Lack of Standardized Government Regulations
Exhibit 23 Impact of High Cost of IVF
Exhibit 24 Successful Outcomes of IVF of At least One Cycle Being Successful Over Six Cycles
Exhibit 25 Impact of Ethical Challenges Related to the IVF Treatment
Exhibit 26 Impact of Limitations & Risks Associated with IVF Treatment
Exhibit 27 Limitations & Risks Associated with ART & IVF Procedures
Exhibit 28 Impact of Covid-19 Adversely Impacting IVF Procedural Volumes
Exhibit 29 Six Month Delay in IVF and Reduction in Live Birth in Different Age groups
Exhibit 30 IVF Devices Market in US 2020–2026 ($ million)
Exhibit 31 IVF Devices Market in US by Product: 2020 & 2026 (% share)
Exhibit 32 IVF Devices Market in US by End-Users
Exhibit 33 In-Vitro Fertilization Devices Market in US by Donor Type
Exhibit 34 Five Forces Analysis 2020
Exhibit 35 Incremental Growth by Product 2020 & 2026
Exhibit 36 In-Vitro Fertilization (IVF) Devices Market in US by Product
Exhibit 37 IVF Devices Market in US by Product: Incremental Growth
Exhibit 38 IVF Devices Market in the US by Product: Absolute Growth
Exhibit 39 IVF Devices Market in US by Consumables: Incremental & Absolute Growth Comparison
Exhibit 40 IFV Devices Market in US by Consumables Market 2020–2026 ($ million)
Exhibit 41 IVF Devices Market in US by Media: Incremental and Absolute Growth Comparison
Exhibit 42 IVF Devices Market in US by Media 2020–2026 ($ million)
Exhibit 43 IVF Devices Market in US by Equipment: Incremental and Absolute Growth Comparison
Exhibit 44 IVF Devices Market in US by Equipment 2020–2026 ($ million)
Exhibit 45 Incremental Growth by End-Users 2020 & 2026
Exhibit 46 In-Vitro Fertilization Devices Market in US by End-Users
Exhibit 47 IVF Devices Market in US by End-Users: Incremental Growth
Exhibit 48 IVF Devices Market in US by End-Users: Absolute Growth
Exhibit 49 IVF Devices Market in US by Fertility Clinics: Incremental & Absolute Growth Comparison
Exhibit 50 IVF Devices Market in US by Fertility Clinics 2020–2026 ($ million)
Exhibit 51 IVF Devices Market in US by Hospitals: Incremental & Absolute Growth Comparison
Exhibit 52 IVF Devices Market in US by Hospitals 2020–2026 ($ million)
Exhibit 53 IVF Devices Market in US by Other End-users: Incremental & Absolute Growth Comparison
Exhibit 54 In-Vitro Fertilization Devices Market in US by Other End-users 2020–2026 ($ million)
Exhibit 55 Incremental Growth by Donor Type 2020 & 2026
Exhibit 56 In-Vitro Fertilization Devices Market in US by Donor Type
Exhibit 57 IVF Market in the UK by Donor Type: Incremental Growth
Exhibit 58 IVF Devices Market in the US by Donor Type: Absolute Growth
Exhibit 59 IVF Devices Market in US by Fresh Non-Donor: Incremental & Absolute Growth Comparison
Exhibit 60 IVF Devices Market in US by Fresh Non-Donor 2020–2026 ($ million)
Exhibit 61 IVF Devices Market in US by Frozen Non-Donor: Incremental & Absolute Growth Comparison
Exhibit 62 IVF Devices Market in US by Frozen Non-Donor 2020–2026 ($ million)
Exhibit 63 IVF Devices Market in US by Fresh Donor: Incremental & Absolute Growth Comparison
Exhibit 64 Steps Involved in the IVF Treatment with Fresh Donor Eggs
Exhibit 65 Success Rate of IVF in US Using Fresh and Frozen Eggs 2019 (% share)
Exhibit 66 Previous Cycles Egg Donor Recipients Underwent in US (% share)
Exhibit 67 IVF Devices Market in US by Fresh Donors 2020–2026 ($ million)
Exhibit 68 IVF Devices Market in US by Frozen Donor: Incremental & Absolute Growth Comparison
Exhibit 69 IVF Devices Market in US by Frozen Donor 2020–2026 ($ million)
Exhibit 70 The Cooper Companies Revenue 2018-2020 ($ million)
Exhibit 71 The Cooper Companies: Sales Revenue by Business Segments 2018-2020 ($ million)
Exhibit 72 The Cooper Companies R& D Expenditure 2018-2020 ($ million)
Exhibit 73 The Coopers Companies’ Cooper Surgical Business Segment Revenue Split 2020 (% share)
Exhibit 74 Vitrolife Sales Revenue 2018-2020 ($ million)
Exhibit 75 Vitrolife Sales Revenue by Region During 2019-2020 ($million)
Exhibit 76 Sales Revenue of Merck Group 2018-2020 ($ million)
Exhibit 77 Merck Group Revenue by Business Segments 2018-2020 ($ million)
List Of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2020
Table 3 Symptoms of Infertility Among Men and Women
Table 4 Popular Fertility Treatment Loans in US
Table 5 Some of the Most Popular Fertility Treatment Grants in the US
Table 6 Fertility-Related Conditions Associated with Obesity in Men
Table 7 Fertility Related Conditions Associated with Obesity in Females
Table 8 Chances of Live Birth by Fifth IVF Cycle
Table 9 Top Five Fertility Clinics in US by Cycles 2017
Table 10 Ethical Challenges Involved in the Process of In-Vitro Fertilization
Table 11 Pregnancy Rate Among Women Undergoing IVF
Table 12 Prominent Players in IVF Devices Market Offering Consumables
Table 13 Prominent Players in Market Offering Media Used in IVF
Table 14 Types of Microscopes Used in IVF Treatment
Table 15 Popular Cryobanks Offering Storage of Sperms, Eggs, & Embryos
Table 16 Top Five IVF Clinics for Women Aged Under 35 by Non-Donor Eggs
Table 17 Top Five IVF Clinics for Women Aged Over 42 by Non-Donor Eggs
Table 18 Competitive Structure Analysis of US IVF Devices Market
Table 19 US IVF Devices Market Key Vendors Ranking 2020
Table 20 The Cooper Companies: Major Product Offerings
Table 21 Cook Medical: Key Medical Specialties
Table 22 Cook Medical: Major Product Offerings
Table 23 Vitrolife: Major Product Offerings
Table 24 FUJIFILM Irvine Scientific: Major Product Offerings Micromanipulation/ICSI Media
Table 25 Merck Group: Major Product Offerings
Table 26 Hamilton Thorne: Major Product Offerings
Table 27 CARL ZEISS: Major Product Offerings
Table 28 Kitazato USA: Major Product Offerings
Table 29 Rocket Medical: Major Product Offerings
Table 30 Thermo Fisher Scientific: Major Product Offerings
Table 31 Thomas Medical: Major Product Offerings
Table 32 Nidacon: Major Product Offerings
Table 33 Esco Lifesciences: Major Product Offerings
Table 34 GYNEMED: Major Product Offerings
Table 35 IVF Devices Market in US by Product 2020−2026 ($ million)
Table 36 IVF Devices Market in US by Product 2020−2026 (% share)
Table 37 IVF Devices Market in US by Donor Type 2020−2026 ($ million)
Table 38 IVF Devices Market in US by Donor Type 2020−2026 (%)
Table 39 IVF Devices Market in US by End-Users 2020−2026 ($ million)
Table 40 IVF Devices Market in US by End-Users 2020−2026 (%)
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Products
4.3.2 Market Segmentation by Procedures
4.3.3 Market Segmentation by End-Users
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Infertility Overview
7.2 IVF Treatment Overview
8 Market Opportunities & Trends
8.1 Technological Advances & Innovations in IVF
8.2 Single Parents & Same-Sex Couples Taking Infertility Treatments
8.3 Financial Assistance Programs & Employer Benefits for Infertility Treatment
8.4 Private Equity/Venture Capital Funding in IVF Clinics
9 Market Growth Enablers
9.1 Increasing Prevalence of Infertility
9.2 Rising Obesity Cases
9.3 Increasing Acceptance of Art Procedures
9.4 Rise in Number of Fertility Clinics
10 Market Restraints
10.1 Lack of Standardized Government Regulations
10.2 High Cost of IVF
10.3 Ethical Challenges Related to IVF Treatment
10.4 Limitations & Risks Associated with IVF Treatment
10.5 COVID-19 Adversely Impacting IVF Procedural Volumes
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Product Insights
11.2.2 End-Users Insights
11.2.3 Donor Type Insights
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Consumables
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Media
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Equipment
12.5.1 Market Overview
12.5.2 Market Size & Forecast
13 End-Users
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Fertility Clinics
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Hospitals
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 Others
13.5.1 Market Overview
13.5.2 Market Size & Forecast
14 Donor Type
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Fresh Non-Donor
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Frozen Non-Donor
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 Fresh Donor
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.6 Frozen Donor
14.6.1 Market Overview
14.6.2 Market Size & Forecast
15 Competitive Landscape
15.1 Competition Overview
15.2 Market Share Analysis
15.2.1 The Cooper Companies
15.2.2 Cook Medical
15.2.3 Vitrolife
15.2.4 FUJIFILM Irvine Scientific
15.2.5 Rocket Medical
15.2.6 KITAZATO USA
15.2.7 Merck Group
15.2.8 Hamilton Thorne
16 Key Company Profiles
16.1 The Cooper Companies
16.1.1 Business Overview
16.1.2 Product Offerings
16.1.3 Key Strategies
16.1.4 Key Strengths
16.1.5 Key Opportunities
16.2 Cook Medical
16.2.1 Business Overview
16.2.2 Product Offerings
16.2.3 Key Strategies
16.2.4 Key Strengths
16.2.5 Key Opportunities
16.3 Vitrolife
16.3.1 Business Overview
16.3.2 Product Offerings
16.3.3 Key Strategies
16.3.4 Key Strengths
16.3.5 Key Opportunities
16.4 FUJIFILM Irvine Scientific
16.4.1 Business Overview
16.4.2 Product Offerings
16.4.3 Key Strategies
16.4.4 Key Strengths
16.4.5 Key Opportunities
16.5 Merck Group
16.5.1 Business Overview
16.5.2 Product Offerings
16.5.3 Key Strategies
16.5.4 Key Strengths
16.5.5 Key Opportunities
16.6 Hamilton Thorne
16.6.1 Business Overview
16.6.2 Product Offerings
16.6.3 Key Strategies
16.6.4 Key Strengths
16.6.5 Key Opportunities
17 Other Prominent Vendors
17.1 CARL ZEISS
17.1.1 Business Overview
17.1.2 Product Offerings
17.2 Kitazato USA
17.2.1 Business Overview
17.2.2 Product Offerings
17.2.3 Key Strategies
17.2.4 Key Strengths
17.2.5 Key Opportunities
17.3 Rocket Medical
17.3.1 Business Overview
17.3.2 Product Offerings
17.3.3 Key Strategies
17.3.4 Key Strengths
17.3.5 Key Opportunities
17.4 Thermo Fisher Scientific
17.4.1 Business Overview
17.4.2 Product Offerings
17.4.3 Key Strategies
17.4.4 Key Strengths
17.5 Thomas Medical
17.5.1 Business Overview
17.5.2 Product Offerings
17.5.3 Key Strategies
17.6 Nidacon
17.6.1 Business Overview
17.6.2 Product Offerings
17.6.3 Key Strategies
17.6.4 Key Strengths
17.7 Esco Lifesciences
17.7.1 Business Overview
17.7.2 Product Offerings
17.7.3 Key Strategies
17.7.4 Key Strengths
17.8 GYNEMED
17.8.1 Business Overview
17.8.2 Product Offerings
17.8.3 Key Strategies
17.8.4 Key Strengths
18 Report Summary
18.1 Key Takeaways
18.2 Strategic Recommendations
19 Quantitative Summary
19.1 Market by Product
19.2 Market by Donor Type
19.3 Market by End-Users
20 Appendix
20.1 Abbreviations
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
How big is the U.S. IVF market?
What is the growth rate of the US in vitro fertilization (IVF) market?
Which segment accounted for the largest in-vitro fertilization market share?
Who are the key players in the US in-vitro fertilization market?
What are some of the technological advancements and innovations in the IVF market?
other RELATED Reports
Infertility Treatment Market - Global Outlook and Forecast 2019-2024
Published : January 2020
Premature Ejaculation Therapeutics Market - Global Outlook and Forecast 2020-2025
Published : March 2020
